Cynthia Levy

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 44

Top Venues

Hepatology communications

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

Clinical liver disease

University of Miami

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Miami Jan 01 2010

United States

Professor of Medicine :: Division of Hepatology

Publications

Nathalie A Pena Polanco, Cynthia Levy
Autoimmune hepatitis and pregnancy. Clinical liver disease 23 (1) (2024)
Douglas Thorburn, Diana J Leeming, William T Barchuk, Ya Wang, Xiaomin Lu, Vladislav A Malkov, Kaori L Ito, Christopher L Bowlus, Cynthia Levy, Zachary Goodman, Morten A Karsdal, Andrew J Muir, Jun Xu
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis. Hepatology communications 8 (7) (2024)
Douglas Thorburn, Diana J Leeming, William T Barchuk, Ya Wang, Xiaomin Lu, Vladislav A Malkov, Kaori L Ito, Christopher L Bowlus, Cynthia Levy, Zachary Goodman, Morten A Karsdal, Andrew J Muir, Jun Xu
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis. Hepatology communications 8 (7) (2024)
Nathalie A Pena Polanco, Cynthia Levy
Autoimmune hepatitis and pregnancy. Clinical liver disease 23 (1) (2024)
Anna K Mann, Liz Allan, Kristen P Wheeden, Amy K Dickey, Cynthia Levy
Diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and x-linked protoporphyria: A patient-friendly summary of the 2023 evidence-based consensus guidelines. Clinical liver disease 23 (1) (2024)
David E J Jones, Ulrich H W Beuers, Alan Bonder, Marco Carbone, Emma L Culver, Jessica Katharine Dyson, Robert G Gish, Bettina E Hansen, Gideon M Hirschfield, Rebecca Jones, Kris Kowdley, Andreas E Kremer, Keith D Lindor, Marlyn J Mayo, George Mells, James Neuberger, Martin Prince, Mark G Swain, Atsushi Tanaka, Douglas Thorburn, Michael Trauner, Palak J Trivedi, Martin Weltman, Andrew D Yeoman, Cynthia Levy
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here? Hepatology (Baltimore, Md.) (2024)
Douglas Thorburn, Diana J Leeming, William T Barchuk, Ya Wang, Xiaomin Lu, Vladislav A Malkov, Kaori L Ito, Christopher L Bowlus, Cynthia Levy, Zachary Goodman, Morten A Karsdal, Andrew J Muir, Jun Xu
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis. Hepatology communications 8 (7) (2024)
Anna K Mann, Liz Allan, Kristen P Wheeden, Amy K Dickey, Cynthia Levy
Diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and x-linked protoporphyria: A patient-friendly summary of the 2023 evidence-based consensus guidelines. Clinical liver disease 23 (1) (2024)
Akshata Moghe, Brendan M McGuire, Cynthia Levy
Acute hepatic porphyrias-A guide for hepatologists. Hepatology (Baltimore, Md.) (2024)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Juan P Trivella, Binu V John, Cynthia Levy
Primary biliary cholangitis: Epidemiology, prognosis, and treatment. Hepatology communications 7 (6) (2023)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
Smriti R Kumar, Cynthia Levy, David S Goldberg
Impact of implementation of national liver review board on liver allocation among patients with primary sclerosing cholangitis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces interleukin-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, Palak J Trivedi, Christophe Corpechot, Adriaan J van der Meer, Willem J Lammers, Pier Maria Battezzati, Keith D Lindor, Frederik Nevens, Kris V Kowdley, Karen Schmidt, Nora Cazzagon, Annarosa Floreani, Andrew L Mason, Aliya Gulamhusein, Cyriel Y Ponsioen, Marco Carbone, Ana Lleo, Marlyn J Mayo, Georgios N Dalekos, Nikolaos K Gatselis, Douglas Thorburn, Xavier P D M J Verhelst, Albert Parés, María Carlota Londoño, Harry L A Janssen, Invernizzi Pietro, Raj Vuppalanchi, Gideon M Hirschfield, Bettina E Hansen, Cynthia Levy, null null
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival. Liver international : official journal of the International Association for the Study of the Liver (2023)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
Invernizzi Pietro, Marco Carbone, David Jones, Cynthia Levy, Nicola Little, Philippe Wiesel, Frederik Nevens, null null
Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trial. Liver international : official journal of the International Association for the Study of the Liver (2023)
Gideon M Hirschfield, Mitchell L Shiffman, Gideon M Hirschfield, Kris V Kowdley, John M Vierling, Cynthia Levy, Andreas E Kremer, Ehud Zigmond, Pietro Andreone, Stuart C Gordon, Christopher L Bowlus, Eric J Lawitz, Richard J Aspinall, Daniel S Pratt, Karina Raikhelson, Maria S Gonzalez-Huezo, Michael A Heneghan, Sook-Hyang Jeong, Alma L Ladrón de Guevara, Marlyn J Mayo, Georgios N Dalekos, Joost Paulus Hubertus Drenth, Ewa Janczewska, Barbara A Leggett, Frederik Nevens, Víctor Vargas, Eli Zuckerman, Christophe Corpechot, Eduardo Fassio, Holger Hinrichsen, Invernizzi Pietro, Palak J Trivedi, Lisa Forman, David E J Jones, Stephen D Ryder, Mark G Swain, Alexandra Steinberg, Pol F Boudes, Yun-Jung Choi, Charles A McWherter, null null
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology (Baltimore, Md.) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Marlyn J Mayo, Elizabeth Carey, Helen T Smith, Andrea R Mospan, Megan McLaughlin, April Thompson, Heather L Morris, Robert Sandefur, W Ray Kim, Christopher Bowlus, null null, Cynthia Levy
Correction to: Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis. Digestive diseases and sciences (2023)
Marlyn J Mayo, John M Vierling, Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield, Guy W Neff, Michael R Galambos, Stuart C Gordon, Brian B Borg, Stephen A Harrison, Paul J Thuluvath, Aparna Goel, Mitchell L Shiffman, Mark G Swain, David E J Jones, Palak J Trivedi, Andreas E Kremer, Richard J Aspinall, David A Sheridan, Yvonne Dörffel, Ke Yang, Yun-Jung Choi, Charles A McWherter
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis. Alimentary pharmacology & therapeutics (2023)
Annika Bergquist, Tobias J Weismüller, Cynthia Levy, Christian Rupp, Deepak Joshi, Jeremy Shanika Nayagam, Aldo J Montano-Loza, Ellina Lytvyak, Ewa Wunsch, Piotr Milkiewicz, Roman Zenouzi, Christoph Schramm, Nora Cazzagon, Annarosa Floreani, Ingalill Friis Liby, Miriam Wiestler, Heiner Wedemeyer, Taotao Zhou, Christian P Strassburg, Eirini I Rigopoulou, George Dalekos, Manasa Narasimman, Xavier Verhelst, Helena Degroote, Mette Vesterhus, Andreas E Kremer, Bennet Bündgens, Fredrik Rorsman, Emma Nilsson, Kristin Kaasen Jørgensen, Erik von Seth, Martin Cornillet Jeannin, Nils Nyhlin, Harry Martin, Stergios Kechagias, Kristine Wiencke, Mårten Werner, Benedetta Terziroli Beretta Piccoli, Marco Marzioni, Helena Isoniemi, Johanna Arola, Agnes Wefer, Jonas Söderling, Martti A Färkkilä, Henrike Lenzen, null null
Impact on follow-up strategies in patients with primary sclerosing cholangitis. Liver international : official journal of the International Association for the Study of the Liver (2022)
Nidah Shabbir Khakoo, Shahnaz Sultan, John M Reynolds, Cynthia Levy
Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis. Digestive diseases and sciences (2022)
Marlyn J Mayo, Elizabeth Carey, Helen T Smith, Andrea R Mospan, Megan McLaughlin, April Thompson, Heather L Morris, Robert Sandefur, W Ray Kim, Christopher Bowlus, null null, Cynthia Levy
Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis. Digestive diseases and sciences (2022)
Andreas E Kremer, Marlyn J Mayo, Gideon Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Alexandra Steinberg, Charles A McWherter, Yun-Jung Choi
Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver (2021)
Andres F Carrion, Keith D Lindor, Cynthia Levy
Safety of fibrates in cholestatic liver diseases. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Binu V John, Bassam Dahman, Yangyang Deng, Nidah S Khakoo, Tamar H Taddei, David E Kaplan, Cynthia Levy
Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis. Liver international : official journal of the International Association for the Study of the Liver (2021)
Cumali Efe, Craig Steven Lammert, Koray Taşçılar, Renumathy Dhanasekaran, Berat Ebik, Fatima Higuera-de la Tijera, Ali Rıza Calışkan, Mirta Peralta, Alessio Gerussi, Hatef Massoumi, Andreea M Catana, Tugrul Purnak, Cristina Rigamonti, Andres Jose Gomez Aldana, Nidah Khakoo, Leyla Nazal, Shalom Frager, Nurhan Demir, Kader Irak, Zeynep Melekoğlu Ellik, Hüseyin Kacmaz, Yasemin Balaban, Kadri Atay, Fatih Eren, Mario Reis Alvares-da-Silva, Laura Cristoferi, Álvaro Urzua, Tuğçe Eşkazan, Bianca Magro, Romee Snijders, Sezgin Barutçu, Ellina Lytvyak, Godolfino Miranda Zazueta, Aylin Demirezer Bolat, Mesut Aydın, Alexandra Heurgue-Berlot, Eleonora De Martin, Nazım Ekin, Sümeyra Yıldırım, Ahmet Yavuz, Murat Bıyık, Graciela Castro Narro, Murat Kıyıcı, Murat Akyıldız, Evrim Kahramanoğlu-Aksoy, Maria Vincent, Rotonya M Carr, Fulya Günşar, Eira Cerda Reyes, Murat Harputoğlu, Costica Aloman, Nikolaos K Gatselis, Yücel Üstündağ, Javier Brahm, Nataly Chris Escajadillo Vargas, Fatih Guzelbulut, Sandro Ruiz Garcia, Jonathan Aguirre, Margarita Anders, Natalia Ratusnu, Ibrahim Hatemi, Manuel Mendizabal, Annarosa Floreani, Stefano Fagiuoli, Marcelo Silva, Ramazan Idilman, Sanjaya Kumar Satapathy, Marina Silveira, Joost Paulus Hubertus Drenth, George N Dalekos, David N Assis, Einar Stefan Björnsson, James L Boyer, Eric M Yoshida, Invernizzi Pietro, Cynthia Levy, Aldo J Montano-Loza, Thomas D Schiano, Ezequiel Ridruejo, Staffan Wahlin
Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis. Liver international : official journal of the International Association for the Study of the Liver (2021)
Christopher L Bowlus, Cynthia Levy
Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis. Alimentary pharmacology & therapeutics 51 (1) (2020)
Liselot W van Erp, Morven Cunningham, Manasa Narasimman, Hamideh Ale Ali, Kartik Jhaveri, Joost P H Drenth, Harry L A Janssen, Cynthia Levy, Gideon M Hirschfield, Bettina E Hansen, Aliya F Gulamhusein
Risk of gallbladder cancer in patients with primary sclerosing cholangitis and radiographically detected gallbladder polyps. Liver international : official journal of the International Association for the Study of the Liver 40 (2) (2019)
Claudia Alves Couto, Débora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Gilda Porta, Cynthia Levy, Antônio Eduardo Benedito Silva, Paulo Bittencourt de Miranda, null null, Roberto José de Carvalho-Filho, Dalton Marques Chaves, Irene Kazue Miura, Paulo Lisboa Bittencourt, Luciana Costa Faria, Andreia Silva Evangelista, Alberto Queiroz Farias, Luciana Lofêgo Gonçalves, Michelle Harriz, Edmundo Pessoa de Almeida Lopes, Gustavo Oliveira Luz, Patrícia Marinho Costa de Oliveira, Elze Maria Gomes Oliveira, Janaina Luz Narciso Schiavon, Tiago Sevá-Pereira
UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER. Arquivos de gastroenterologia 56 (2) (2019)
Jordan Goldstein, Cynthia Levy
Novel and emerging therapies for cholestatic liver diseases. Liver international : official journal of the International Association for the Study of the Liver 38 (9) (2018)

Cynthia Levy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Cynthia Levy